Ruth E. Langley

MRC Clinical Trials Unit at UCL — United Kingdom

Medicine · Health Sciences

41h-index15.8kcitations193works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(56), Prostate Cancer Treatment and Research(42), Esophageal Cancer Research and Treatment(41), Lung Cancer Treatments and Mutations(23), Inflammatory mediators and NSAID effects(21)

Publications193 total

Understanding How Aspirin Prevents Metastasis
New England Journal of Medicine·2025
Platelet activation, aspirin, and cancer: From basic science to clinical trials
Pharmacological Reviews·2025Open Access
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Open Access CRIS of the University of Bern·2025Open Access
Preferences between three options for androgen deprivation therapy: a focus group study
British Journal of Urology·2025· 1 citedOpen Access
Determining the Impact of Histology on the Incidence, Pattern, and Timing of Recurrences in Patients with Renal Cell Carcinoma: A Pooled Analysis from the SORCE and ASSURE Trials
European Urology Open Science·2025· 1 citedOpen Access
A Hybrid Transformer-Graph Model for Multi-Class Lymph Node Segmentation in Histopathology
Lecture notes in computer science·2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
The Lancet Oncology·2025· 12 citedOpen Access
Suspending the NHS medicines repurposing programme in England is a missed opportunity
BMJ·2025Open Access
412P Tumour-free lymph node microarchitecture associates with tumour location-specific survival in oesophagogastric cancer: Results from the OE05 and ST03 trials
Annals of Oncology·2025Open Access
413P Mismatch repair deficiency (MMRd) in esophagogastric adenocarcinoma (ADC) following chemotherapy for resectable disease: Correlation with survival and recurrence patterns from ST03 and OE05 trials
Annals of Oncology·2025Open Access
P309 A multi-centre recruitment process evaluation of COLO-PREVENT: a platform for developing COLOrectal cancer PREVENTion therapies
2025
Determining the optimal use of approved drugs in oncology
The Lancet Oncology·2025· 4 cited
Abstract CT252: COLO-PREVENT: A platform for developing colorectal cancer prevention therapies
Cancer Research·2025
Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer—Randomised comparison from the STAMPEDE trial platform.
Journal of Clinical Oncology·2025· 4 cited
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction
JAMA Network Open·2024· 9 citedOpen Access
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition
British Journal of Cancer·2024· 2 citedOpen Access
483P Germinal centre microarchitecture in tumour-negative lymph nodes after different neoadjuvant chemotherapy regimens in patients with oesophagogastric cancer: Results from the UK MRC OE05 trial
Annals of Oncology·2024Open Access
Re: Bertrand Tombal, Sean Collins, Alicia K. Morgans, et al. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. Eur Urol 2023;84:579–87
European Urology·2024
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials
European Journal of Cancer·2024· 6 cited
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials
Contemporary Clinical Trials·2024· 7 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Mahesh Parmar(20), David Cunningham(15), Matthew Nankivell(14), Matthew R. Sydes(12), William Allum(11), Duncan C. Gilbert(11), Nicholas D. James(10), Heike I. Grabsch(10), Sally Stenning(9), Noel W. Clarke(9), Fay Cafferty(9), Alicia Okines(8), David P. Dearnaley(7), Zafar Malik(7), Stephen Falk(6), Chris Brawley(6), Alex Hoyle(6), Gerhardt Attard(6), Silke Gillessen(6), Clare Gilson(6)